Total Payments
$7,677
2024 Payments
$484.37
Companies
24
Transactions
72
Medicare Patients
742
Medicare Billing
$87,706
Payment Breakdown by Category
Consulting$5,009 (65.2%)
Food & Beverage$2,668 (34.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,009 | 3 | 65.2% |
| Food and Beverage | $2,668 | 69 | 34.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stimwave Technologies Incorporated | $4,522 | 3 | $0 (2018) |
| Eli Lilly and Company | $575.00 | 1 | $0 (2022) |
| Medtronic, Inc. | $561.35 | 14 | $0 (2024) |
| Abbott Laboratories | $387.63 | 6 | $0 (2024) |
| Boston Scientific Corporation | $268.33 | 8 | $0 (2024) |
| Nevro Corp. | $162.43 | 2 | $0 (2024) |
| Orthofix Medical, Inc. | $150.06 | 3 | $0 (2022) |
| Globus Medical, Inc. | $132.52 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $123.65 | 1 | $0 (2022) |
| Allergan Inc. | $109.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $484.37 | 11 | Boston Scientific Corporation ($145.83) |
| 2023 | $324.51 | 11 | Medtronic, Inc. ($162.21) |
| 2022 | $1,355 | 15 | Eli Lilly and Company ($575.00) |
| 2021 | $381.06 | 8 | Medtronic, Inc. ($247.32) |
| 2020 | $89.40 | 5 | Boston Scientific Corporation ($58.90) |
| 2019 | $75.46 | 4 | ARBOR PHARMACEUTICALS, INC. ($34.13) |
| 2018 | $4,761 | 12 | Stimwave Technologies Incorporated ($4,522) |
| 2017 | $206.83 | 6 | Allergan Inc. ($109.79) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/15/2024 | Globus Medical, Inc. | TLIF (Device) | Food and Beverage | In-kind items and services | $43.06 | General |
| Category: Spine/Spine Surgery | ||||||
| 09/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/23/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $145.83 | General |
| 07/18/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Pain management | ||||||
| 05/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/30/2024 | Globus Medical, Inc. | ExcelsiusGPS Robotic Navigation System (Device) | Food and Beverage | In-kind items and services | $40.68 | General |
| Category: Spine/Spine Surgery | ||||||
| 04/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $76.86 | General |
| Category: Neuromodulation | ||||||
| 04/05/2024 | Globus Medical, Inc. | ExcelsiusGPS Robotic Navigation System (Device) | Food and Beverage | In-kind items and services | $48.78 | General |
| Category: Spine/Spine Surgery | ||||||
| 02/14/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 12/09/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/23/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/20/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/05/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/06/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 03/28/2023 | Azurity Pharmaceuticals, Inc. | Gliadel (Drug) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: Neurology | ||||||
| 03/22/2023 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 03/16/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/09/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $114.21 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/08/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/01/2022 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| 09/15/2022 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 07/21/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $108.39 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 162 | 218 | $75,683 | $19,198 |
| 2022 | 11 | 237 | 324 | $116,874 | $29,239 |
| 2021 | 10 | 182 | 227 | $77,491 | $20,307 |
| 2020 | 8 | 161 | 214 | $83,933 | $18,962 |
Total Patients
742
Total Services
983
Medicare Billing
$87,706
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 102 | $29,784 | $7,836 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $18,618 | $4,000 | 21.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 11 | 17 | $6,749 | $1,503 | 22.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 11 | 11 | $3,916 | $1,386 | 35.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 11 | 14 | $4,606 | $1,324 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $4,642 | $1,167 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 21 | $3,780 | $1,021 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 13 | $3,588 | $961.22 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 101 | $29,066 | $8,194 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $16,050 | $3,952 | 24.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 32 | $12,704 | $3,099 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $10,550 | $2,528 | 24.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 19 | 25 | $9,925 | $2,447 | 24.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 22 | 29 | $10,469 | $1,926 | 18.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 12 | 16 | $6,048 | $1,746 | 28.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 18 | $9,162 | $1,698 | 18.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 11 | 12 | $4,272 | $1,493 | 34.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 28 | $5,040 | $1,282 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $3,588 | $873.95 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 47 | $13,724 | $3,930 | 28.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 36 | $9,936 | $2,458 | 24.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $9,594 | $2,345 | 24.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $9,630 | $2,305 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 20 | $7,940 | $1,959 | 24.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $7,174 | $1,882 | 26.2% |
About Nitin Sekhri
Nitin Sekhri is a Pain Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992958060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nitin Sekhri has received a total of $7,677 in payments from pharmaceutical and medical device companies, with $484.37 received in 2024. These payments were reported across 72 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($5,009).
As a Medicare-enrolled provider, Sekhri has provided services to 742 Medicare beneficiaries, totaling 983 services with total Medicare billing of $87,706. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Valhalla, NY
- Active Since 11/03/2008
- Last Updated 01/14/2014
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1992958060
Products in Payments
- INTELLIS (Device) $222.35
- PROCLAIM (Device) $212.92
- INTELLIS ADAPTIVESTIM (Device) $177.69
- Cervical-Stim (Device) $150.06
- Omnia (Device) $142.89
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $134.94
- RELISTOR (Drug) $123.65
- BOTOX THERAPEUTIC (Biological) $109.79
- Qutenza (Drug) $108.39
- BOTOX (Biological) $96.38
- ExcelsiusGPS Robotic Navigation System (Device) $89.46
- SCS IPGs (Device) $83.76
- GENERAL - PAIN MANAGEMENT (Device) $81.40
- Horizant (Drug) $65.77
- Proclaim DRG IPG (Device) $60.45
- LYRICA (Drug) $58.54
- Catheters and Needles (Device) $53.29
- Nalu Neurostimulation System (Device) $50.39
- QUTENZA (Drug) $46.93
- TLIF (Device) $43.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.